Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Bone Marrow Transplantation

• Publication date

  1992-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 1422499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation.

  1992cited by this paper
• Origin and function of adherent lymphokine activated killer cells in patients with chronic myeloid leukaemia who relapse following bone marrow transplantation

  1991cited by this paper
• Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells.

  1991cited by this paper
• Effect of cyclosporin A on lymphopoiesis. III. Augmentation of the generation of natural killer cells in bone marrow transplanted mice treated with cyclosporin A.

  1991cited by this paper
• Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect.

  1990cited by this paper
• Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia.

  1990cited by this paper
• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.

  1990cited by this paper
• Graft-versus-leukemia reactions after bone marrow transplantation.

  1990cited by this paper
• Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow.

  1990cited by this paper
• Effect of cyclosporin A on lymphopoiesis. I. Absence of mature T cells in thymus and periphery of bone marrow transplanted mice treated with cyclosporin A.

  1989cited by this paper
• Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.

  1989cited by this paper
• High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.

  1989cited by this paper
• Competition between recipient and donor cells after bone marrow transplantation for chronic myeloid leukaemia

  1988cited by this paper
• Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase.

  1988cited by this paper
• Graft-versus-leukemia following bone marrow transplantation.

  1987cited by this paper
• Marrow transplantation for the treatment of chronic myelogenous leukemia.

  1986cited by this paper
• Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.

  1985cited by this paper
• Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man?

  1978cited by this paper

• Handbook of Statistics in Clinical Oncology

  2025cites this paper
• Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients.

  2021cites this paper
• Transplantation of hematopoietic stem cells: historical aspects

  2018cites this paper
• Effects of preemptive interferon-α monotherapy in acute leukemia patients with relapse tendency after allogeneic hematopoietic stem cell transplantation: a case-control study

  2018cites this paper
• Genetically enhanced T lymphocytes and the intensive care unit

  2018cites this paper
• Hematopoietic Stem Cell Transplantation for Cancer

  2017cites this paper
• Donor Lymphocyte Infusions Used to Treat Mixed-Chimeric and High-Risk Patient Populations in the Relapsed and Nonrelapsed Settings after Allogeneic Transplantation for Hematologic Malignancies Are Associated with High Five-Year Survival if Persistent Full Donor Chimerism Is Obtained or Maintained.

  2017cites this paper
• T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome

  2016cites this paper
• Transplant for MDS: challenges and emerging strategies.

  2015cites this paper
• Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.

  2015cites this paper
• Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T-Cells in Cancer Immunotherapy

  2015cites this paper
• Complications de l'immunothérapie par transfusion de lymphocytes de donneur après greffe de cellules souches hématopoïétiques

  2014cites this paper
• G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete engraftment after allogeneic hematopoietic transplantation

  2013cites this paper
• transplantation comparative analysis of unrelated versus matched sibling donor Allogeneic bone marrow transplantation for chronic myelogenous leukemia

  2013cites this paper
• Advances in Stem Cell Research

  2012cites this paper
• A long road of T-cells to cure cancer: from adoptive immunotherapy with unspecific cellular products to donor lymphocyte infusions and transfer of engineered tumor-specific T-cells.

  2012cites this paper
• Nonengraftment Haploidentical Cellular Therapy for Hematologic Malignancies

  2012influential citation
• Cellular Therapy for Hematology Malignancies: Allogeneic Hematopoietic Stem Transplantation, Graft-Versus-Host Disease, and Graft Versus Leukemia Effects

  2012cites this paper
• Methods and biomarkers for outcome prediction after allogeneic hematopoietic stem cell transplantation

  2012cites this paper
• Cellular therapy following allogeneic stem-cell transplantation

  2011cites this paper
• allogeneic bone marrow transplantation recombinant human interleukin-2 to treat leukemia relapse after Allogeneic cell therapy with donor peripheral blood cells and

  2011cites this paper
• A more efficient killing machine : how CpG-oligodeoxynucleotides enhance natural killer cell cytokine production and cytotoxicity against leukemia initiating cells

  2011influential citation
• Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation

  2011cites this paper
• Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years

  2011cites this paper
• Granulocytic sarcoma of the stomach: relapse after hematopoietic stem-cell transplantation for chronic myeloid leukemia.

  2010cites this paper
• The graft-versus-tumor effect in pediatric malignancy.

  2010cites this paper
• Abrupt cessation of immunosuppression in a patient with persistent acute lymphoblastic leukaemia following allogeneic transplantation.

  2010cites this paper
• Ph-positive leukemias in the era of modern cytogenetics, molecular biology, tyrosine kinase inhibitors and hematopoietic stem cell transplantation

  2010cites this paper
• NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

  2010cites this paper
• First International Workshop on the Biology , Prevention and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation : Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

  2010cites this paper
• Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions.

  2010cites this paper
• Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited.

  2010cites this paper
• Effective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantation

  2009cites this paper
• chromosome-bearing (Ph1+) human leukemia lines can also Allogeneic T-cell clones able to selectively destroy Philadelphia

  2009cites this paper
• Donor lymphocyte infusions for acute myeloid leukaemia.

  2008cites this paper
• Immunologic targeting of the cancer stem cell

  2008cites this paper
• Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect.

  2008cites this paper
• Donor Lymphocyte Infusions Clinical Applications and the Graft‐versus‐Leukemia Effect

  2008cites this paper
• Complete Remission Induced by Filgrastim (rhG-CSF) in the Case of Relapsed Acute Lymphoblastic Leukemia after Unrelated Cord Blood Transplantation

  2008cites this paper
• Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment.

  2007cites this paper
• Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.

  2007cites this paper
• Inv (11)(p15q21) in donor‐derived Ph‐negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stemcell transplantation

  2007cites this paper
• Novel approaches in allogeneic stem cell transplantation

  2006cites this paper
• Clinical Applications of Hematopoietic Stem Cells

  2006cites this paper
• Induction of tumor immunity following allogeneic stem cell transplantation.

  2006cites this paper
• Harnessing the Potential of Graft-vs-Tumor

  2006cites this paper
• Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation

  2006cites this paper
• Biologic Principles of Hematopoietic Stem Cell Transplantation

  2006cites this paper
• Donor leukocyte infusions in myeloid malignancies: new strategies.

  2006cites this paper
• Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.

  2006cites this paper
• Practical Implementation of the Continual Reassessment Method

  2005cites this paper
• Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study.

  2005cites this paper
• Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre‐emptive immunotherapy

  2005influential citation
• Stem Cell TransplantationResearch Paper

  2005cites this paper
• Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.

  2005cites this paper
• Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.

  2005cites this paper
• Stem cell transplantation: graft-mediated antileukemia effects.

  2005cites this paper
• Donor lymphocyte infusions.

  2004cites this paper
• CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study

  2004cites this paper
• Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3+ and CD4+ lymphocytes

  2004cites this paper
• Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

  2004cites this paper
• Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

  2004cites this paper
• ‘GVHD’: graft-versus-host disease or graft-versus-Hodgkin's disease? an old acronym with new meaning

  2003cites this paper
• [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].

  2003cites this paper
• Donor Leukocyte Infusions

  2003cites this paper
• Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.

  2003cites this paper
• Adoptive Cellular Therapy: A Therapeutic Reality?

  2002cites this paper
• Filgrastim Treatment of Acute Myelogenous Leukemia (M7) Relapse after Allogeneic Peripheral Stem Cell Transplantation Resulting in Both Graft-versus-Leukemia Effect with Cytogenetic Remission and Chronic Graft-versus-Host Disease Manifesting as Polyserositis and Subsequent Bronchiolitis Obliterans w

  2002cites this paper
• Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.

  2002cites this paper
• Main Session I

  2002cites this paper
• Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.

  2002cites this paper
• Umbilical cord blood transplantation: where do we stand?

  2002cites this paper
• Engraftment and Immune Reconstitution

  2002cites this paper
• Unrelated Donor Leukocyte Infusions to Treat Relapse after Unrelated Donor Bone Marrow Transplantation

  2002cites this paper
• 6. NON - M Y E LOA B L A T I V E HEMATOPOIETIC STEM CELL TRANSPLANT ATION (NST) IN THE

  2002cites this paper
• [Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism].

  2002cites this paper
• Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.

  2002cites this paper
• Bone marrow transplantation for multiple myeloma: where we are today

  2002cites this paper
• Induction of graft-versus-host disease and a graft-versus-leukemia effect using ubenimex in a patient with infantile leukemia relapsing after an unrelated cord blood transplant

  2002cites this paper
• Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease

  2002cites this paper
• Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.

  2002cites this paper
• Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.

  2002cites this paper
• Graft versus Leukemia and Graft versus Tumor Activity

  2002cites this paper
• The Graft-versus-Tumor Potential of Allogeneic Cell Therapy: An Update on Donor Leukocyte Infusions and Nonmyeloablative Allogeneic Stem Cell Transplantation

  2001cites this paper
• Allogeneic bone marrow transplantation with reduced conditioning (RC‐BMT)

  2001cites this paper
• Chemotherapy and granulocyte colony stimulating factor‐mobilized blood cell infusion followed by interferon‐α for relapsed malignancy after allogeneic bone marrow transplantation

  2001cites this paper
• A decade of progress in allogeneic hematopoietic cell transplantation: 1990-2000.

  2001cites this paper
• Novel approaches to allogeneic stem cell therapy

  2001cites this paper
• TRANSFORMING GROWTH FACTOR-b INHIBITS LYMPHOKINE ACTIVATED KILLER CYTOTOXICITY OF BONE MARROW CELLS

  2001cites this paper
• Exploiting graft-versus-tumour responses using donor leukocyte infusions.

  2001cites this paper
• Effector Cells and Mechanisms of the GVL Effect

  2000cites this paper
• High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant

  2000cites this paper
• Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia

  2000cites this paper
• Adoptive allogeneic immunotherapy--history and future perspectives.

  2000cites this paper
• Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: Non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect

  2000cites this paper
• GVL Effects in Human Marrow Stem-Cell Transplants

  2000cites this paper
• Effects of Mixed Chimerism and Immune Modulation on GVHD, Disease Recurrence and Survival after HLA-identical Marrow Transplantation for Hematologic Malignancies

  2000cites this paper
• Adoptive allogeneic cell-mediated immunotherapy and nonmyeloablative stem-cell transplantation

  2000cites this paper
• Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.

  2000cites this paper
• Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man

  2000cites this paper